Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon
Our findings showed that diabetes was significantly the most prevalent comorbid NCD amongst sputum-positive TB patients (<i>p</i> < 0.001). HIV status, occupation, body mass index (BMI), and alcohol intake were not significantly associated with having at least one comorbidity. Implementing public health intervention programmes such as systematic screening of TB patients for NCDs especially diabetes is highly recommended for better control of these diseases.
Authors
- Fanny Fri Fombad (ORCID: https://orcid.org/0000-0003-2575-9884)
- Melanie J. Newport (ORCID: https://orcid.org/0000-0002-8946-7525)
- Henry Dilonga Meriki (ORCID: https://orcid.org/0000-0002-9148-0171)
- Juluis Visnel Foyet (ORCID: https://orcid.org/0000-0001-6564-9167)
- Eyoab Iyasu Gebremeskel (ORCID: https://orcid.org/0000-0001-5080-7409)
- Jerome Fru Cho
- Kebede Deribe (ORCID: https://orcid.org/0000-0002-8526-6996)
- Manuel Ritter (ORCID: https://orcid.org/0000-0001-8667-2067)
- Lucy Cho Nchang (ORCID: https://orcid.org/0009-0008-0546-0109)
- Chefor Magha
- Simon J. Waddell (ORCID: https://orcid.org/0000-0002-3684-9116)
- Michael Weldeslassie
- Achim Hoerauf (ORCID: https://orcid.org/0000-0002-8671-3831)
- Desmond Akumtoh Nkimbeng
- Nancielle Mbiatong Tchatat
- Samuel Wanji (ORCID: https://orcid.org/0000-0003-0022-8366)
- Tatiana Djikeussi Katcho
- Frank Noel Nietcho
- Kidist Bobosha
Institutions
- Brighton and Sussex Medical School (GB)
- University of Buea (CM)
- University of Sussex (GB)
- University Hospital Bonn (DE)
- Children's Investment Fund Foundation (GB)
- German Center for Infection Research (DE)
- Armauer Hansen Research Institute (ET)
- University of Asmara (ER)
Publication Details
- Journal
- Frontiers in Tuberculosis
- Published
- 2024-10-02
- DOI
- https://doi.org/10.3389/ftubr.2024.1433856
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Wellcome Trust
- Deutsche Forschungsgemeinschaft
- European and Developing Countries Clinical Trials Partnership